Clinical and economic outcomes of pharmacological stress tests in patients with a history of COVID‐19

Mostrar otras versiones (1)

BACKGROUND: Despite millions of COVID‐19 cases in the United States, it remains unknown whether a history of COVID‐19 infection impacts the safety of pharmacologic myocardial perfusion imaging stress testing (pharmacologic MPI). HYPOTHESIS: The aim of this study was to assess if a prior COVID‐19 inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Skali, Hicham, Walker, David, Jiang, Jeanette, Gurumoorthy, Giridharan, Davies, Kalatu, Kimura, Tomomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Clinical Trial Result
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189073/
https://www.ncbi.nlm.nih.gov/pubmed/36951276
http://dx.doi.org/10.1002/clc.24008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189073/
https://www.ncbi.nlm.nih.gov/pubmed/36951276
http://dx.doi.org/10.1002/clc.24008

Ejemplares similares